GSK Investigational Site
Dippoldiswalde, Saxony 01744
0 studies enrolling now · 2 studies all time
What they study most
Herpes Zoster, Respiratory Syncytial Virus Infections
Studies at this site
- Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women — Completed
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older — Completed